Histone deacetylase inhibitors – a new tool to treat cancer

This publication has 75 references indexed in Scilit:

• Maintenance of chromatin states: an open-and-shut case.
  Current Opinion in Cell Biology, 2003
• Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code
  Annals of the New York Academy of Sciences, 2003
• Senescence and epigenetic dysregulation in cancer
  The International Journal of Biochemistry & Cell Biology, 2002
• P53 gene mutations: Case study of a clinical marker for solid tumors
  Seminars in Oncology, 2002
• Histone deacetylases and cancer: causes and therapies
  Nature Reviews Cancer, 2001
• Histone deacetylase inhibitors as new cancer drugs
  Current Opinion in Oncology, 2001
• Translating the Histone Code
  Science, 2001
• Histone acetylation and the cell-cycle in cancer
  Frontiers in Bioscience-Landmark, 2001
• Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
  JNCI Journal of the National Cancer Institute, 2000
• Twenty-Five Years of the Nucleosome, Fundamental Particle of the Eukaryote Chromosome
  Cell, 1999